[The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
作者信息
Fang Q Y, Hao Q S, Gong X Y, Wang J, Li Q H, Yuan T, Tian Z, Liu K Q, Li Y, Liu Y T, Gong B F, Wang Y, Wei H, Zhou C L, Lin D, Liu B C, Wei S N, Zhang G J, Wang J X, Mi Y C
机构信息
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):432-435. doi: 10.3760/cma.j.issn.0253-2727.2021.05.015.
Abstract
摘要
相似文献
1
[The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):432-435. doi: 10.3760/cma.j.issn.0253-2727.2021.05.015.
2
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Blood. 2009 Apr 23;113(17):3918-24. doi: 10.1182/blood-2008-10-184069. Epub 2008 Dec 23.
3
[Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Zhonghua Yi Xue Za Zhi. 2022 Jul 5;102(25):1910-1917. doi: 10.3760/cma.j.cn112137-20211025-02358.
4
Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
J Clin Oncol. 2009 Sep 10;27(26):4352-6. doi: 10.1200/JCO.2009.22.0996. Epub 2009 Jul 27.
5
Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol. 2018 Jan;40(1):e1-e8. doi: 10.1097/MPH.0000000000001006.
6
[Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Apr;25(2):587-591. doi: 10.7534/j.issn.1009-2137.2017.02.050.
7
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
Haematologica. 2009 Oct;94(10):1383-90. doi: 10.3324/haematol.2008.005272.
8
Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
Leukemia. 2013 Jan;27(1):41-7. doi: 10.1038/leu.2012.176. Epub 2012 Jul 3.
9
Prognostic significance of mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol.
Leuk Lymphoma. 2022 Jul;63(7):1624-1633. doi: 10.1080/10428194.2022.2032033. Epub 2022 Feb 6.
10
Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia.
Haematologica. 2009 Oct;94(10):1338-40. doi: 10.3324/haematol.2009.012047.
引用本文的文献
1
A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia.
Ann Med. 2024 Dec;56(1):2427365. doi: 10.1080/07853890.2024.2427365. Epub 2024 Nov 18.
本文引用的文献
1
CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia.
Exp Mol Med. 2019 Jan 11;51(1):1-15. doi: 10.1038/s12276-018-0195-x.
2
Notch Signaling in the Tumor Microenvironment.
Cancer Cell. 2018 Oct 8;34(4):536-548. doi: 10.1016/j.ccell.2018.07.009. Epub 2018 Aug 23.
3
Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.
Int J Mol Sci. 2017 Sep 5;18(9):1904. doi: 10.3390/ijms18091904.
4
T-cell acute lymphoblastic leukemia.
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):580-588. doi: 10.1182/asheducation-2016.1.580.
5
Risk stratification of T-cell Acute Lymphoblastic Leukemia patients based on gene expression, mutations and copy number variation.
Leuk Res. 2016 Jun;45:33-9. doi: 10.1016/j.leukres.2016.03.002. Epub 2016 Apr 1.
6
[Optimal treatment of adult Ph negative acute lymphoblastic leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2014 Oct;35(10):873-9. doi: 10.3760/cma.j.issn.0253-2727.2014.10.001.
7
Early T-cell precursor acute lymphoblastic leukaemia.
Curr Opin Hematol. 2013 Jul;20(4):369-73. doi: 10.1097/MOH.0b013e3283623c61.
8
The molecular basis of T cell acute lymphoblastic leukemia.
J Clin Invest. 2012 Oct;122(10):3398-406. doi: 10.1172/JCI61269. Epub 2012 Oct 1.
9
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
Haematologica. 2009 Oct;94(10):1383-90. doi: 10.3324/haematol.2008.005272.
10
Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia.
Haematologica. 2009 Oct;94(10):1338-40. doi: 10.3324/haematol.2009.012047.
Zotero 插件